A combination of growth hormone and octreotide for the treatment of malignant insulinoma

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 4, 1997, Pages 265-266

  Meeking, D R ^a   Steur, A ^a   Cavan, D A ^a   Sonksen P H ^a   Lowy, C L ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; BENDROFLUMETHIAZIDE; C PEPTIDE; DIAZOXIDE; DOXORUBICIN; GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; OCTREOTIDE; STREPTOZOCIN;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; HUMAN; HYPOGLYCEMIA; INSULINOMA; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030806635     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Moertal CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-Doxorubicin, Streptozocin-Fluorouracil or Chlorozotocin in the treatment of advanced islet-cell carcinoma. N. Eng. J. Med. 1992; 326: 519-523.
2. von Eyben FE, Grodum E, Gjessing HJ, Hagen C, Nielsen H. Metabolic remission with octreotide in patients with insulinoma. J. Int. Med. 1994; 235: 245-248.
3. Nesovic M, Ciric J, Radojkovic S, Zarkovic M, Durovic M. Improvement of metastatic endocrine tumours of the pancreas by hepatic artery chemoembolisation. J. Endocrinol. Invest. 1992; 15: 543-547.
4. Maiche AG, Pyrhonen S, Maki-Hokkonen H. Treatment response to natural leucocyte interferon-alpha in relapsing malignant insulinoma with severe hypoglycaemia. Acta Oncol., 1992; 31: 365-366.